22 Mar
Innovative Cancer Therapy for Tomorrow: Melphalan, Arsenic Trioxide, and Ascorbic Acid for Multiple Myeloma
Presenter: James Berenson, MD, Medical and Scientific Director, Institute for Myeloma and Bone Cancer Research, West Hollywood, California Multiple myeloma (MM) is an incurable B-cell malignancy, and resistance develops in nearly all patients. Most patients develop renal insufficiency, which is associated with poor survival.